ORYZON Genomics to Present at Stifel 2016 Healthcare Conference
BARCELONA, SPAIN and CAMBRIDGE MA.
Oryzon Genomics (ISIN Code: ES0167733015, ORY), a public clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with strong unmet medical need, announced that Dr. Carlos Buesa Arjol, Chief Executive Officer, will present an overview of the Company at 2:15 p.m. EST on Tuesday, November 15, at the Stifel 2016 Healthcare Conference. The conference will take place at the Lotte New York Palace Hotel in New York City.
The Stifel 2016 Healthcare Conference attracts top institutional investors. The goal of this conference is to provide them with high-level access to senior management and industry experts, showcase dynamic emerging companies, and investigate critical trends that are driving our economy.